Back to News
Market Impact: 0.3

Honeywell vs. 3M: Which Industrial Conglomerate Stock Should You Bet On?

HONMMM
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookCapital Returns (Dividends / Buybacks)Analyst EstimatesLegal & LitigationMarket Technicals & FlowsTransportation & Logistics
Honeywell vs. 3M: Which Industrial Conglomerate Stock Should You Bet On?

A comparison of industrial conglomerates Honeywell (HON) and 3M (MMM) for 2025 indicates Honeywell is better positioned, driven by strong commercial aerospace, defense, and building automation segments, projecting 4-5% organic revenue growth despite increased debt and weakness in industrial automation. Conversely, 3M, while seeing momentum in safety and industrial, faces significant headwinds from soft consumer retail demand, automotive OEM weakness, and ongoing earplug litigation, leading to a projected 8.8% sales decline for 2025. Despite Honeywell's slightly higher valuation, its stronger growth estimates and diversified portfolio make it the preferred investment over 3M, which is burdened by legal and market challenges.

Analysis

A comparative analysis of Honeywell (HON) and 3M (MMM) reveals divergent operational outlooks despite both being positioned to benefit from aerospace and industrial trends. Honeywell exhibits robust fundamental strength, driven by significant year-over-year growth in its key segments during the second quarter of 2025: commercial aviation aftermarket (+7%), defense and space (+13%), and building automation (+8%). This momentum supports a full-year organic revenue growth forecast of 4-5%. However, this positive outlook is tempered by a 5% sales decline in its Industrial Automation segment and a substantial increase in long-term debt to $30.2 billion to fund acquisitions. Conversely, 3M is grappling with significant headwinds. While its Safety and Industrial segment saw a modest 2.5% organic sales increase in the first half, the company is challenged by weak consumer retail demand, softness in the automotive OEM business, and a major overhang from ongoing earplug litigation. Critically, consensus estimates project an 8.8% year-over-year sales decline for 3M in 2025, contrasting sharply with Honeywell's expected 5.7% sales growth. Although 3M's stock has slightly outperformed in the past six months (+6.4% vs. HON's +3.4%), its forward P/E of 18.89x is considerably above its three-year median, while Honeywell's P/E of 19.61x is in line with its historical average, suggesting HON's valuation is better supported by its growth prospects.